İngilizce Yayınlar

- A new atypical antipsychotic: quetiapine-induced sexual dysfunctions - An Open Clinical Trial - Antioxidant enzyme activities - Antioxidant enzyme and malondialdehyde levels in patient - Antioxidant enzyme and malondialdehyde levels - Antioxidant enzyme and malondialdehyde values
- Cingulate gyrus volumetry in drug free bipolar patients and patients treated with valproate or valproate and quetiapine - Comp Psychiatry - Dissociative Disorders in Turkish Inpatients - Effect of sertindole on QTc interval in patients with schizophrenia - Efficacy of citalopram and moclobemide in patients with social phobia - Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder
- Free radicals in patients with post-traumatic stress disorder - High serum leptin levels in depressive disorders with atypical features - Hipocampal 1 H MRS in first episode bipolar I patients - Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine. - Hippocampus and amygdalar volumes in patients with refractory - Lipid peroxidation
- Mixed Type Masturbation A Case Report - Neopterin levels and dexamethasone suppression test in obsessive–compulsive disorder - Neopterin production in posttraumatic stress disorder before and after pharmacotherapy - Neurochemistry of the hippocampus in patients with obsessive–compulsive disorder - Nizatidine for the treatment of patients with quetiapine-induced weight gain - Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain
- Plasma nitrate values in patients with obsessivecompulsive disorder - Plasma nitric oxide and leptin values in patients with olanzapine-induced weight gain - Quetiapine augmentation in patients with treatment resistant obsessive compulsive disorder - Quetiapine Is Not Associated with Increase in Prolactin Secretion in Contrast to Haloperidol - Quetiapine-associated and dose-related hypomania in a woman with schizophrenia - Serum Antioxidant Enzymes and Malondialdehyde Levels
- Serum cholesterol and leptin levels in Patients with borderline Personality Disorder - Serum folate and homocysteine levels in patients with obsessive - compulsive disorder - Serum ghrelin and cholesterol values in suicide attempters - Serum iron levels in schizophrenic patients with or without akathisia - Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts - Serum leptin and cholesterol values in violent and non-violent suicide attempters
- Serum leptin and cholesterol values in suicide attempters - Serum leptin and cholesterol Levels in Patients with bipolar disorder - Serum leptin levels in obsessive-compulsive disorder - Serum leptin levels in patients with premature ejaculation - Sexuel Medicine chapter - Sildenafil use in patients with olanzapine-induced erectile
- Sociodemographic and clinical characteristics - Switching to tianeptine in patients with antidepressantinduced - The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia - The efficacy of citalopram in the treatment of premature - Total antioxidant response in patients with schizophrenia - Volumetric investigation of brain regions in patients with conversion disorder
- Volumetric MRI assessment of brain regions in patients with refractory obsessive-compulsive disorder - Volumetric MRI study of key brain regions implicated in obsessive-compulsive disorder - Weight gain and serum leptin levels in patients on lithium treatment - Weight gain, serum leptin and triglyceride levels in patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol